Top Markets
#1 MowCat MowCat +49.46%
#2 aPriori aPriori +24.90%
#3 Velvet Velvet +24.78%
#4 Bitway Bitway +24.55%
#5 Fake World Assets Fake World Assets +17.70%
#6 OVERTAKE OVERTAKE +17.39%
#7 Verus Coin Verus Coin +15.91%
#8 Derive Derive +14.40%
#9 Merlin's Seal BTC Merlin's Seal BTC +13.40%
#10 Perle Perle +12.08%
Coin of the day
MowCat MowCat
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc.

OBLN
Kedudukan dalam Saham #34657
Obalon Therapeutics, Inc. operates as a fully integrated medical device... Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensive system incorporates an ingestible capsule that houses an inflatable balloon connected to a microcatheter. It also includes the Obalon Navigation System console, a specialized hardware and software platform used to precisely monitor and display the balloon's location during its placement. Further components are the Obalon Touch Inflation Dispenser, a semi-automated, portable instrument for inflating the balloon once it's correctly positioned, and a single-use canister containing a gas mixture. By February 27, 2020, Obalon Therapeutics managed three company-owned treatment centers situated in California. The firm was established in 2008 and bases its operations in Carlsbad, California.
Harga Saham
$3.05
Disegerakkan terakhir: 2021-06-15
Modal Pasaran
$5.16M
Perubahan (1 hari)
-5.86%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Obalon Therapeutics, Inc. (OBLN)

Kategori

Healthcare
Nisbah P/E bagi Obalon Therapeutics, Inc. (OBLN)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Obalon Therapeutics, Inc., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Obalon Therapeutics, Inc. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.